Sponsor content
192 result(s) found, displaying 71 to 80
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 7.5 mg/0.5 mL solution for injection pre-filled pen.
-
Australian public assessment report (AusPar)Mounjaro (tirzepatide) is approved for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
-
Prescription medicine decision summaryOmvoh (mirikizumab) is approved to treat moderately to severely active ulcerative colitis.
-
Prescription medicine registrationActive ingredients: mirikizumab.
-
Prescription medicine decision summaryWe have approved Retevmo (selpercatinib) to treat adult patients with Non-Small Cell Lung Cancer (NSCLC).
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: selpercatinib.
-
Prescription medicine registrationActive ingredients: baricitinib.